HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kensuke Nakamura Selected Research

fosphenytoin (Cerebyx)

5/2021Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.
8/2020Phenytoin versus fosphenytoin for second-line treatment of status epilepticus: propensity score matching analysis using a nationwide inpatient database.
3/2020Changes in Real-world Practice Patterns of Antiepileptic Drugs for Status Epilepticus: A Nationwide Observational Study in Japan.
1/2020Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database.
6/2017Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kensuke Nakamura Research Topics

Disease

9Infections
12/2022 - 08/2011
8Sepsis (Septicemia)
12/2021 - 08/2013
7Critical Illness (Critically Ill)
05/2022 - 10/2019
7Heart Failure
03/2022 - 01/2018
6Status Epilepticus (Complex Partial Status Epilepticus)
05/2021 - 02/2015
6Neoplasms (Cancer)
08/2020 - 10/2013
5Pain (Aches)
12/2022 - 03/2014
5Delirium
12/2022 - 01/2021
5COVID-19
12/2022 - 01/2021
5Polyps
06/2022 - 10/2013
5Hypertension (High Blood Pressure)
10/2021 - 04/2015
4Pneumonia (Pneumonitis)
01/2022 - 04/2013
4Septic Shock (Toxic Shock Syndrome)
08/2021 - 05/2013
4Inflammation (Inflammations)
01/2021 - 01/2019
3Stroke (Strokes)
08/2021 - 11/2012
3Seizures (Absence Seizure)
05/2021 - 08/2014
3Hemolysis
10/2014 - 12/2009
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2014 - 08/2011
2Cushing Syndrome
07/2022 - 04/2021
2Hypernatremia
03/2022 - 01/2016
2Non-Muscle Invasive Bladder Neoplasms
01/2022 - 01/2017
2Pulmonary Embolism
01/2022 - 07/2015
2Communicable Diseases (Infectious Diseases)
01/2022 - 07/2015
2Tachycardia (Tachyarrhythmias)
09/2021 - 10/2016
2Edema (Dropsy)
09/2021 - 09/2014
2Hypotension (Low Blood Pressure)
09/2021 - 05/2021
2Cognitive Dysfunction
07/2021 - 12/2020
2Wounds and Injuries (Trauma)
03/2021 - 01/2018
2Muscular Diseases (Myopathy)
01/2021 - 01/2020
2Hemorrhagic Shock
12/2020 - 10/2013
2Hypovolemia
12/2020 - 07/2013
2Thrombosis (Thrombus)
08/2020 - 06/2016
2Disseminated Intravascular Coagulation
08/2020 - 06/2016
2Cardiomyopathies (Cardiomyopathy)
04/2019 - 05/2013
2Body Weight (Weight, Body)
10/2018 - 08/2018
2Kidney Diseases (Kidney Disease)
11/2017 - 06/2016
2Thrombocytopenia (Thrombopenia)
06/2016 - 07/2013
2Thrombotic Thrombocytopenic Purpura
06/2016 - 04/2015
2Hyperammonemia
08/2014 - 10/2013
2Heart Arrest (Cardiac Arrest)
10/2013 - 01/2012
1Fibrosis (Cirrhosis)
01/2022

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
12/2022 - 08/2011
5Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 12/2009
5Diazepam (Valium)FDA LinkGeneric
05/2021 - 02/2015
5fosphenytoin (Cerebyx)FDA LinkGeneric
05/2021 - 06/2017
5Biomarkers (Surrogate Marker)IBA
03/2021 - 10/2013
4Indicators and Reagents (Reagents)IBA
10/2021 - 04/2013
4CytokinesIBA
10/2014 - 10/2013
3CreatinineIBA
07/2022 - 03/2018
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2011
3PotassiumIBA
08/2021 - 12/2009
3Levetiracetam (Keppra)FDA LinkGeneric
05/2021 - 06/2017
3ConnectinIBA
03/2021 - 01/2020
3Blood Glucose (Blood Sugar)IBA
01/2021 - 11/2012
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 08/2013
3SonazoidIBA
08/2019 - 01/2012
3Cisplatin (Platino)FDA LinkGeneric
01/2017 - 01/2012
2Bisoprolol (Concor)FDA LinkGeneric
09/2021 - 10/2016
2Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2021 - 01/2021
2EnzymesIBA
07/2021 - 06/2016
2ElementsIBA
03/2021 - 01/2021
2CatecholaminesIBA
01/2021 - 04/2019
2Dacarbazine (DIC)FDA LinkGeneric
08/2020 - 06/2016
2BenzodiazepinesIBA
08/2020 - 06/2017
2Anticonvulsants (Antiepileptic Drugs)IBA
08/2020 - 03/2020
2Phenytoin (Dilantin)FDA LinkGeneric
08/2020 - 03/2020
2C-Reactive ProteinIBA
01/2020 - 09/2014
2Interleukin-10 (Interleukin 10)IBA
01/2018 - 10/2013
2thiamine triphosphorate (TTP)IBA
09/2017 - 06/2016
2ThrombomodulinIBA
06/2016 - 04/2015
2Edetic Acid (EDTA)FDA Link
04/2015 - 07/2013
2AmmoniaIBA
08/2014 - 10/2013
2Contrast MediaIBA
01/2014 - 01/2012
2Messenger RNA (mRNA)IBA
11/2013 - 10/2013
2EndotoxinsIBA
10/2013 - 05/2013
2SodiumIBA
12/2011 - 12/2009
2Adenosine Triphosphate (ATP)IBA
12/2011 - 12/2009
1Analgesics (Analgesic Drugs)IBA
10/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2022
1MucinsIBA
06/2022
1TolvaptanFDA Link
03/2022
1COVID-19 VaccinesIBA
01/2022
1Coloring Agents (Dyes)IBA
01/2022
1N 30IBA
01/2022
1Amyloid (Amyloid Fibrils)IBA
01/2022

Therapy/Procedure

10Critical Care (Surgical Intensive Care)
10/2022 - 06/2016
7Therapeutics
01/2022 - 07/2015
3Nutrition Therapy (Medical Nutrition Therapy)
12/2022 - 03/2021
3Artificial Respiration (Mechanical Ventilation)
09/2022 - 08/2020
3Aftercare (After-Treatment)
10/2018 - 07/2013
3Microbubbles
01/2017 - 01/2012
2Mechanical Ventilators (Ventilator)
10/2022 - 08/2020
2Early Ambulation
05/2022 - 08/2021
2Glycemic Control
01/2022 - 01/2021
2Drug Therapy (Chemotherapy)
01/2022 - 01/2017
2Microspheres (Microsphere)
01/2022 - 04/2017
2Resuscitation
12/2020 - 01/2012
2Length of Stay
03/2020 - 01/2020
2Cardiopulmonary Resuscitation (CPR)
12/2018 - 03/2015
2Catheters
04/2017 - 09/2015